$1.05
-0.02 (-1.87%)
Open$1.07
Previous Close$1.07
Day High$1.08
Day Low$1.03
52W High$3.09
52W Low$1.20
Volume—
Avg Volume79.7K
Market Cap210.10M
P/E Ratio2.43
EPS$0.63
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,678.1% upside
Current
$1.05
$1.05
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 402.36M | 332.15M | 81.33M |
| Net Income | -38,432,386 | -28,553,035 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -22,020,825 | -17,269,096 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |